Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2008, Article ID 736060, 8 pages
http://dx.doi.org/10.1155/2008/736060
Research Article

Expression and Hydroxylamine Cleavage of Thymosin Alpha 1 Concatemer

Room 345, College of Life Sciences, Zhejiang University, Hangzhou 310058, China

Received 3 December 2007; Revised 21 February 2008; Accepted 15 June 2008

Academic Editor: Nina Prak

Copyright © 2008 Liang Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Goldstein, T. L. K. Low, M. McAdoo et al., “Thymosin a1: isolation and sequence analysis of an immunologically active thymic polypeptide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 74, no. 2, pp. 725–729, 1977. View at Publisher · View at Google Scholar
  2. T. L. K. Low, G. B. Thurman, M. McAdoo et al., “The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin a1 and polypeptide ß1 from calf thymus,” The Journal of Biological Chemistry, vol. 254, no. 3, pp. 981–986, 1979. View at Google Scholar
  3. C. S. Sarandeses, G. Covelo, C. Díaz-Jullien, and M. Freire, “Prothymosin α is processed to thymosin α1 and thymosin α11 by a lysosomal asparaginyl endopeptidase,” The Journal of Biological Chemistry, vol. 278, no. 15, pp. 13286–13293, 2003. View at Publisher · View at Google Scholar
  4. A. P. Knutsen, J. J. Freeman, K. R. Mueller, S. T. Roodman, and J. D. Bouhasin, “Thymosin-α1 stimulates maturation of CD34+ stem cells into CD3+4+ cells in an in vitro thymic epithelia organ coculture model,” International Journal of Immunopharmacology, vol. 21, no. 1, pp. 15–26, 1999. View at Publisher · View at Google Scholar
  5. K. D. Leichtling, S. A. Serrate, and M. B. Sztein, “Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes,” International Journal of Immunopharmacology, vol. 12, no. 1, pp. 19–29, 1990. View at Publisher · View at Google Scholar
  6. J. A. Moshier, M. G. Mutchnick, J. Dosescu et al., “Thymosin-a1, but not interferon-a, specifically inhibits anchorage-independent growth of hepatitis B viral transfected HepG2 cells,” Journal of Hepatology, vol. 25, no. 6, pp. 814–820, 1996. View at Publisher · View at Google Scholar
  7. D. Bianco-Batlles, C. W. Naylor, J. A. Moshier, J. Dosescu, and P. H. Naylor, “Clonal growth inhibition as a bioassay for thymosin alpha1: inactivation of Tα1 by trifluroacetic acid,” Cellular and Molecular Biology, vol. 47, no. 1, pp. 157–160, 2001. View at Google Scholar
  8. C. A. Baumann, M. Badamchian, and A. L. Goldstein, “Thymosin α1, antagonizes dexamethasone and CD3-induced apoptosis of CD4+CD8+ thymocytes through the activation of cAMP and protein kinase C dependent second messenger pathways,” Mechanisms of Ageing and Development, vol. 94, no. 1–3, pp. 85–101, 1997. View at Publisher · View at Google Scholar
  9. R. Roy, S. M. Singh, and A. Shanker, “Mechanism of thymocyte apoptosis induced by serum of tumor-bearing host: the molecular events involved and their inhibition by thymosin α-1,” International Journal of Immunopharmacology, vol. 22, no. 4, pp. 309–321, 2000. View at Publisher · View at Google Scholar
  10. J. Beuth, J. M. Schierholz, and G. Mayer, “Thymosin α1 application augments immune response and down-regulates tumor weight and organ colonization in BALB/c-mice,” Cancer Letters, vol. 159, no. 1, pp. 9–13, 2000. View at Publisher · View at Google Scholar
  11. C. Giuliani, G. Napolitano, A. Mastino et al., “Thymosin-a1 regulates MHC class I expression in FRTL-5 cells at transcriptional level,” European Journal of Immunology, vol. 30, no. 3, pp. 778–786, 2000. View at Publisher · View at Google Scholar
  12. Y. Huang, Z. Chen, C. Zhou, H. Yao, M. Li, and C. Xu, “The modulation of thymosin alpha 1 in the maturation, differentiation and function of murine bone marrow-derived dendritic cells in the absence or presence of tumor necrosis factor-α,” International Immunopharmacology, vol. 4, no. 4, pp. 539–546, 2004. View at Publisher · View at Google Scholar
  13. E. Tzehoval, M. B. Szteiu, and A. L. Goldstein, “Thymosius α1 and β4 potentiate the antigen-presenting capacity of macrophages,” Immunopharmacology, vol. 18, no. 2, pp. 107–113, 1989. View at Publisher · View at Google Scholar
  14. J. W. Hadden, “Thymic endocrinology,” Annals of the New York Academy of Sciences, vol. 840, pp. 352–358, 1998. View at Publisher · View at Google Scholar
  15. G. Rasi, P. Pierimarchi, P. Sinibaldi Vallebona, F. Colella, and E. Garaci, “Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma,” International Immunopharmacology, vol. 3, no. 8, pp. 1169–1176, 2003. View at Publisher · View at Google Scholar
  16. S. Moscarella, G. Buzzelli, R. G. Romanelli et al., “Interferon and thymosin combination therapy in naive patients with chronic hepatitis C: preliminary results,” Liver, vol. 18, no. 5, pp. 366–369, 1998. View at Google Scholar
  17. E. Garaci, F. Pica, G. Rasi, and C. Favalli, “Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application,” International Journal of Immunopharmacology, vol. 22, no. 12, pp. 1067–1076, 2000. View at Publisher · View at Google Scholar
  18. A. Billich, “Thymosin α1: SciClone Pharmaceuticals,” Current Opinion in Investigational Drugs, vol. 3, no. 5, pp. 698–707, 2002. View at Google Scholar
  19. P.-F. Chen, H.-Y. Zhang, G.-F. Fu, G.-X. Xu, and Y.-Y. Hou, “Overexpression of soluble human thymosin alpha 1 in Escherichia coli,” Acta Biochimica et Biophysica Sinica, vol. 37, no. 2, pp. 147–151, 2005. View at Google Scholar
  20. S. Yi, A. Brickenden, and W.-Y. Choy, “A new protocol for high-yield purification of recombinant human prothymosin α expressed in Escherichia coli for NMR studies,” Protein Expression and Purification, vol. 57, no. 1, pp. 1–8, 2008. View at Publisher · View at Google Scholar
  21. H.-B. Park, S.-H. Pyo, S.-S. Hong, and J.-H. Kim, “Optimization of the hydroxylamine cleavage of an expressed fusion protein to produce a recombinant antimicrobial peptide,” Biotechnology Letters, vol. 23, no. 8, pp. 637–641, 2001. View at Publisher · View at Google Scholar
  22. Y. Chen, L. Zhao, G. Shen et al., “Expression and analysis of thymosin a1 concatemer in Escherichia coli,” Biotechnology and Applied Biochemistry, vol. 49, no. 1, pp. 51–56, 2008. View at Publisher · View at Google Scholar
  23. L. Qiu, B. Y. Guo, H. Miao et al., “Study on biological function of prothymosin a and its DNA microarray analysis,” Academic Journal of Second Military Medical University, vol. 23, no. 6, pp. 639–642, 2002. View at Google Scholar
  24. P. Bornstein and G. Balian, “Cleavage at Asn—Gly bonds with hydroxylamine,” Methods in Enzymology, vol. 47, pp. 132–145, 1977. View at Publisher · View at Google Scholar
  25. C. Lin, X. Li, P. Wang, and J. Mei, “Construction and expression of recombinant human thymosin alpha 1,” Journal of Zhejiang University of Technology, vol. 33, no. 3, pp. 306–309, 2005. View at Google Scholar
  26. M. Antorini, U. Breme, P. Caccia et al., “Hydroxylamine-induced cleavage of the asparaginyl–glycine motif in the production of recombinant proteins: the case of insulin-like growth factor I,” Protein Expression and Purification, vol. 11, no. 1, pp. 135–147, 1997. View at Publisher · View at Google Scholar
  27. S. J. Milner, S. M. Thomas, F. J. Ballard, and G. L. Francis, “Optimization of the hydroxylamine cleavage of an expressed fusion protein to produce recombinant human insulin-like growth factor (IGF)-I,” Biotechnology and Bioengineering, vol. 50, no. 3, pp. 265–272, 1996. View at Publisher · View at Google Scholar
  28. H. Jörnvall, “Acetylation of protein N-terminal amino groups structural observations on α amino acetylated proteins,” Journal of Theoretical Biology, vol. 55, no. 1, pp. 1–12, 1975. View at Publisher · View at Google Scholar